Compare BCHT & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCHT | IXHL |
|---|---|---|
| Founded | N/A | 2001 |
| Country | United States | Australia |
| Employees | 15 | N/A |
| Industry | Industrial Machinery/Components | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.0M | 45.0M |
| IPO Year | 2026 | 2024 |
| Metric | BCHT | IXHL |
|---|---|---|
| Price | $1.62 | $3.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 96.2K | ★ 460.8K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,000.00 |
| Revenue This Year | $13.42 | N/A |
| Revenue Next Year | $61.22 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.61 | $0.11 |
| 52 Week High | $2.45 | $6.39 |
| Indicator | BCHT | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 30.60 | 60.88 |
| Support Level | N/A | $0.34 |
| Resistance Level | $2.33 | $3.68 |
| Average True Range (ATR) | 0.18 | 0.30 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 7.06 | 86.49 |
Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.